Penguin On-Site | Founder and CEO Dr. Zou Xiaoliang Leads Weiming Penguin’s Delegation to the 7th World Health Expo
Article images may contain Chinese text.



During a booth interview, Weiming Penguin founder and CEO Dr. Zou Xiaoliang gave a systematic presentation of several company achievements from 2024–2025:

During the expo, Weiming Penguin reached preliminary cooperation agreements with several companies. Looking ahead, the integration of AI and the healthcare industry will create new business sectors on a trillion scale.
Chen Dongsheng, president of the Hubei Chushang Federation, noted that AI is achieving breakthroughs in areas such as new drug discovery and development, gene editing, remote diagnosis and treatment, and surgical robotics, driving a comprehensive upgrade of China’s healthcare industry. He specifically mentioned that the combination of AI and biotechnology will reshape healthcare models—for example, by accelerating drug discovery and optimizing diagnosis and treatment processes through intelligent algorithms, while also driving the transition to smarter medical devices. Weiming Penguin’s technological innovations provide the industry with a complete solution, from improving efficiency to restructuring ecosystems.






